Evidence map›Paper›PMID 40837652›Full record

ArticleAfrican health sciences2025

Short and Long term glycemic control among Type 2 DM patients in a resource-limited setting.

Ijeoma Angela Meka, Chika Juliet Okwor, Ekene Joy Arum, Ochuko Otokunefor, Obumneme Benneth Anyim, Michael Ikechukwu Ogamba

Abstract read
In one paragraph

Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ijeoma Angela MekaDepartment of Chemical Pathology, College of Medicine, University of Nigeria/University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu State, Nigeria.
Chika Juliet OkworDepartment of Chemical Pathology, College of Medicine, University of Nigeria/University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu State, Nigeria.
Ekene Joy ArumDepartment of Chemical Pathology, College of Medicine, University of Nigeria/University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu State, Nigeria.
Ochuko OtokuneforDepartment of Chemical Pathology, College of Health Sciences, University of Port Harcourt, Rivers State, Nigeria.
Obumneme Benneth AnyimDepartment of Internal Medicine, University of Nigeria Teaching Hospital. Ituku/Ozalla, Enugu, Nigeria.
Michael Ikechukwu OgambaDepartment of Chemical Pathology, PAMO University of Medical Sciences, Port Harcourt, Rivers State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes Mellitus is a chronic disease condition and one of public health importance in Africa and indeed globally. Its potential complications can be mitigated by tight control of blood glucose, achievable by both short and long term glucose monitoring. The values of these measures are expected to both be within target, but for some reasons, sometimes these values become discordant. Objective: This study is aimed at determining the pattern of short and long term glycemic control prevalent among Type 2 diabetic patients in the study environment and the extent of the discordance between them. Methods: A cross-sectional study carried out at University of Nigeria Teaching Hospital, Enugu. Research participants comprised consenting adults with Type 2 Diabetes Mellitus. Fasting plasma glucose and glycated hemoglobin were used to assess short and long term glycemic control respectively. Results: The study included 148 participants (60 males and 88 females). Glycated haemoglobin (HbAlc) correlated significantly with Fasting Plasma Glucose (FPG) (P < 0.00001). Prevalence of optimal long and short term glycemic control was 42.6% and 35.8% respectively. The proportion of individuals with concordance between FPG and HbA1c was 116 (78.4%) while 32 (21.6%) had discordant values. Conclusion: Glycemic control, both long and short terms, was sub-optimal among participants. Discordance observed between HbA1c and FPG creates some dilemma in clinical decision making, and calls for guidelines and uniformity in the clinical management of these conditions.

Indexed as

Blood GlucoseDiabetes Mellitus, Type 2Glycated HemoglobinGlycemic ControlAdultAgedCross-Sectional StudiesFastingFemaleHumansMaleMiddle AgedNigeriaResource-Limited SettingsBlood GlucoseGlycated HemoglobinDiabetes MellitusdiscordanceFasting Plasma glucoseglycemic controlHbA1c

Identifiers

PMID40837652
PMCPMC12361954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.